sorafenib has been researched along with shikonin in 2 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (shikonin) | Trials (shikonin) | Recent Studies (post-2010) (shikonin) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 660 | 2 | 505 |
| Protein | Taxonomy | sorafenib (IC50) | shikonin (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 0.1392 | |
| DNA topoisomerase 2-alpha | Homo sapiens (human) | 6.6 | |
| Pyruvate kinase PKM | Homo sapiens (human) | 6.2933 | |
| M-phase inducer phosphatase 1 | Homo sapiens (human) | 0.22 | |
| M-phase inducer phosphatase 2 | Homo sapiens (human) | 0.4 | |
| DNA topoisomerase 2-beta | Homo sapiens (human) | 6.6 | |
| Class A sortase SrtA | Staphylococcus aureus | 2.65 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, Z; Zhang, L | 1 |
| Cui, Y; Feng, W; Liu, S; Liu, Y; Rong, L; Shao, X; Shi, W; Wang, Z; Zhang, H | 1 |
1 review(s) available for sorafenib and shikonin
| Article | Year |
|---|---|
Coumarin-containing hybrids and their anticancer activities.
Topics: Animals; Antineoplastic Agents; Coumarins; Drug Design; Drug Discovery; Humans; Neoplasms; Structure-Activity Relationship | 2019 |
1 other study(ies) available for sorafenib and shikonin
| Article | Year |
|---|---|
Enhancing Tumor Therapy of Fe(III)-Shikonin Supramolecular Nanomedicine via Triple Ferroptosis Amplification.
Topics: Cell Line, Tumor; Ferric Compounds; Ferroptosis; Glutathione; Hydrogen Peroxide; Nanomedicine; Naphthoquinones; Sorafenib | 2022 |